Brian Goff

CIK 1546216 · Chief Executive Officer · last filed 2026-06-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.63M

Companies

3

Total Filings

40

Lifetime Open-Market Net

-$5.41M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NTLA Director 32,609 $12.11 $394.9K $0 3 2026-06-10
AGIO Chief Executive Officer 177,604 $29.46 $5.23M -$5.41M 15 2026-04-06
Baxalta Inc (BXLT) Delisted EVP and President, Hematology 67,030 $0 5 2016-03-08

Recent Filings · Page 4 of 4

40 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-06-12 Sell (S) −1,645 -$195.0K
2018-03-02 Grant (A) +8,940 $0
2018-02-08 Mixed +14,243 -$192.0K
2017-06-09 Grant (A) +14,719 $0
2016-06-07 Mixed −67,166 $0
2016-03-08 Baxalta Inc (BXLT) Delisted Tax (F) −267 -$10.6K EDGAR
2016-03-07 Baxalta Inc (BXLT) Delisted Mixed +33,964 -$64.5K EDGAR
2016-02-17 Baxalta Inc (BXLT) Delisted Mixed +527 -$20.8K EDGAR
2015-08-13 Baxalta Inc (BXLT) Delisted Grant (A) +292 $0 EDGAR
2015-07-06 Baxalta Inc (BXLT) Delisted Mixed +32,308 $0 EDGAR
Showing 3140 of 40
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.